Development
Alto Neuroscience, Inc.
ANRO
$2.57
$0.197.98%
NYSE
| 12/31/2022 | |||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.34M | ||||
| Total Receivables | 546.00K | ||||
| Inventory | -- | ||||
| Prepaid Expenses | 330.00K | ||||
| Finance Division Loans and Leases Current | -- | ||||
| Total Finance Division Other Current Assets | -- | ||||
| Other Current Assets | -- | ||||
| Total Current Assets | 49.22M | ||||
|
|
|||||
| Total Current Assets | 49.22M | ||||
| Net Property, Plant & Equipment | 1.58M | ||||
| Long-term Investments | -- | ||||
| Goodwill | -- | ||||
| Total Other Intangibles | -- | ||||
| Finance Div Loans & Leases LT | -- | ||||
| Total Finance Div Other LT Assets | -- | ||||
| Total Other Assets | 55.00K | ||||
| Total Assets | 50.85M | ||||
|
|
|||||
| Total Accounts Payable | 1.61M | ||||
| Total Accrued Expenses | 3.67M | ||||
| Short-term Debt | -- | ||||
| Current Portion of Long-Term Debt/Capital Leases | -- | ||||
| Finance Division Debt Current | 283.00K | ||||
| Total Finance Division Other Current Liabilities | -- | ||||
| Total Other Current Liabilities | -- | ||||
| Total Current Liabilities | 5.56M | ||||
|
|
|||||
| Total Current Liabilities | 5.56M | ||||
| Long-Term Debt | 9.47M | ||||
| Short-term Debt | -- | ||||
| Capital Leases | 123.00K | ||||
| Finance Division Debt Non Current | -- | ||||
| Total Finance Division Other Non Current Liabilities | -- | ||||
| Total Other Liabilities | -- | ||||
| Total Liabilities | 15.15M | ||||
|
|
|||||
| Common Stock & APIC | 2.30M | ||||
| Retained Earnings | -40.66M | ||||
| Treasury Stock & Other | -46.00K | ||||
| Total Common Equity | -38.41M | ||||
|
|
|||||
| Preferred Stock Redeemable | -- | ||||
| Preferred Stock Non Redeemable | -- | ||||
| Preferred Stock Convertible | 72.24M | ||||
| Preferred Stock, Others | 1.88M | ||||
| Total Preferred Equity | 74.11M | ||||
|
|
|||||
| Total Common Equity | -38.41M | ||||
| Total Preferred Equity | 74.11M | ||||
| Total Minority Interest | -- | ||||
| Total Equity | 35.71M | ||||
|
|
|||||